Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Researchers identify possible treatment targets for myelodysplasia syndromes

Researchers identify possible treatment targets for myelodysplasia syndromes

Fred Hutch’s new Evergreen Fund to promote commercialization of research into lifesaving therapies

Fred Hutch’s new Evergreen Fund to promote commercialization of research into lifesaving therapies

Combination of diabetes and hypertension drugs can effectively treat cancer

Combination of diabetes and hypertension drugs can effectively treat cancer

UC researchers uncover obesity-related protein's role in leukemia development

UC researchers uncover obesity-related protein's role in leukemia development

FDA awards accelerated approval to new ovarian cancer drug

FDA awards accelerated approval to new ovarian cancer drug

New clinical study for children with AML aims to kill leukemia cells and minimize cardiac damage

New clinical study for children with AML aims to kill leukemia cells and minimize cardiac damage

Mayo Clinic creates genetic test to help guide diagnosis, treatment of lymphoma patients

Mayo Clinic creates genetic test to help guide diagnosis, treatment of lymphoma patients

Newborns with CMV may have increased risk of developing acute lymphocytic leukemia

Newborns with CMV may have increased risk of developing acute lymphocytic leukemia

Scientists isolate and characterize therapy-resistant dormant leukemia cells

Scientists isolate and characterize therapy-resistant dormant leukemia cells

Scientists develop first functional biological pacemaker from human stem cells

Scientists develop first functional biological pacemaker from human stem cells

New technology that increases Natural Killer cells to stop cancers gets licensed

New technology that increases Natural Killer cells to stop cancers gets licensed

Phenotypic Personalized Medicine could surmount treatment challenges for acute lymphoblastic leukemia

Phenotypic Personalized Medicine could surmount treatment challenges for acute lymphoblastic leukemia

Personalized cancer vaccine improves outcomes for patients with AML, clinical study shows

Personalized cancer vaccine improves outcomes for patients with AML, clinical study shows

Stem cell-based risk scoring tool could predict AML patient’s response to standard treatment

Stem cell-based risk scoring tool could predict AML patient’s response to standard treatment

New research reveals role of two genetic mutations in subset of acute myeloid leukemia

New research reveals role of two genetic mutations in subset of acute myeloid leukemia

Research findings point to inherited genetic basis of ALL risk in children

Research findings point to inherited genetic basis of ALL risk in children

Experimental T-cell therapy shows promise in preventing AML relapse

Experimental T-cell therapy shows promise in preventing AML relapse

Scientists discover ribosomal protein-based cancer signature

Scientists discover ribosomal protein-based cancer signature

Scientists identify potential dual-acting therapeutic strategy for aggressive form of breast cancer

Scientists identify potential dual-acting therapeutic strategy for aggressive form of breast cancer

Simple, coordinated approach can improve chances of survival for high-risk AML patients

Simple, coordinated approach can improve chances of survival for high-risk AML patients